Different Gene Sets Are Associated With Azacitidine Response In Vitro Versus in Myelodysplastic Syndrome Patients

Myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic disorders characterized by dysplasia, ineffective hematopoiesis, and predisposition to secondary acute myeloid leukemias (sAML). Azacitidine (AZA) is the standard care for high-risk MDS patients not eligible for allogenic bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Pannérer, Marguerite-Marie, Diesch, Jeannine, Casquero, Raquel, Maher, Michael, Garcia, Olga, Haferlach, Torsten, Zuber, Johannes, Kündgen, Andrea, Götze, Katharina S., Buschbeck, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605795/
https://www.ncbi.nlm.nih.gov/pubmed/36310757
http://dx.doi.org/10.1097/HS9.0000000000000792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605795/
https://www.ncbi.nlm.nih.gov/pubmed/36310757
http://dx.doi.org/10.1097/HS9.0000000000000792

Ejemplares similares